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Abstract
How the T cell antigen receptor (TCR) discriminates between molecularly related peptide/Major Histocompatibility Complex
(pMHC) ligands and converts this information into different possible signaling outcomes is still not understood. One current
model proposes that strong pMHC ligands, but not weak ones, induce a conformational change in the TCR. Evidence
supporting this comes from a pull-down assay that detects ligand-induced binding of the TCR to the N-terminal SH3
domain of the adapter protein Nck, and also from studies with a neoepitope-specific antibody. Both methods rely on the
exposure of a polyproline sequence in the CD3e subunit of the TCR, and neither indicates whether the conformational
change is transmitted to other CD3 subunits. Using a protease-sensitivity assay, we now show that the cytoplasmic tails of
CD3e and CD3f subunits become fully protected from degradation upon TCR triggering. These results suggest that the TCR
conformational change is transmitted to the tails of CD3e and CD3f, and perhaps all CD3 subunits. Furthermore, the
resistance to protease digestion suggests that CD3 cytoplasmic tails adopt a compact structure in the triggered TCR. These
results are consistent with a model in which transduction of the conformational change induced upon TCR triggering
promotes condensation and shielding of the CD3 cytoplasmic tails.
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Introduction
Upon ligand binding, membrane receptors have to transmit
information from their ectodomains to their cytoplasmic tails, and
several mechanisms have been proposed to account for how this
happens. One way would be to simply increase the local
concentration of cytoplasmic tails by promoting aggregation of
the ectodomains, which can be achieved by crosslinking with a
multivalent ligand, or could even be induced by a monovalent
ligand, if this binding promotes a conformational change which
results in aggregation. The archetypal receptor aggregation
mechanism is the activation of membrane receptor tyrosine
kinases. Dimerization of these receptors results in activation of
their cytoplasmic tyrosine kinase domains and auto-transphos-
phorylation of their tails [1,2]. A second possible mechanism
involves a conformational change in the cytoplasmic tails
themselves, somehow transmitted from the ectodomains. The
clearest example of this is provided by G protein-coupled receptors
[3,4]. The aggregation and conformational-change mechanisms
are not mutually exclusive; indeed it has been suggested that
membrane protein tyrosine kinase receptors also undergo a
conformational change [5]. To date, much evidence has been
gathered which strongly suggests that several receptors of
immunological interest undergo a conformational change upon
ligand binding. These include the erythropoietin receptor, the
tumor necrosis factor receptors, Fas, the interleukin-6 receptor,
and the B cell receptor [6–10]. In multichain membrane receptors
the conformational change induced upon ligand binding could be
a result of rearrangement of the quaternary structure of the
complex.
The T cell receptor (TCR) complex is composed of ligand-
binding subunits (TCRa and TCRb) and signal transducing
subunits (CD3c,CD3d,CD3e and CD3f [CD247]) [11–13]. The
ligand of the TCR consists of a peptide antigen bound to major
histocompatibility complex (MHC) class I or class II molecules.
Assembly studies, transfection and reconstitution experiments, and
detergent dissociation studies suggest that the TCR complex
components are organized as dimers [reviewed in [14]]. CD3e
forms non-covalently-bound alternate dimers with CD3c and
CD3d, TCRa forms disulfide-linked dimers with TCRb, and
CD3f is expressed in the form of disulfide-linked homodimers.
In spite of significant advances in understanding how the TCR
signal is propagated within the cell, little is known about the
mechanisms that initiate TCR signaling. A number of models have
been proposed, including oligomerization of the TCR complex
[15,16], conformational changes occurring within a single TCRa/
b heterodimer or within the complete TCR complex [17,18],
geometrical rearrangements within a multivalent TCR complex
[19], and segregation of tyrosine kinases and phosphatases from
the TCR complex [20,21]. The poor ability of monovalent (Fab)
anti-CD3 antibodies to stimulate T cells compared with bivalent
antibodies has long suggested ligand-induced oligomerization as a
necessary component of the activation mechanism [22–24]. This
model has been reinforced by experiments comparing monomeric
PLoS ONE | www.plosone.org 1 2008 | Volume 3 | Issue 3 | e1747Figure 1. Effect of TCR ligation on the susceptibility of CD3e and CD3f to limited proteolysis. (A) A cartoon of the CD3e and CD3f
subunits showing potential trypsin cleavage sites (arrows). Transmembrane domains are indicated with striped boxes, the polyproline sequence (PPS)
with an open box, and the foreign Flag epitope, appended to the N-terminus of CD3e, with a dotted square. The relative positions of the ITAMs within
the cytoplasmic tails are marked. (B) Addition of an anti-CD3 antibody that induces TCR conformational change protects the tail of CD3e from trypsin
proteolysis. The indicated concentrations of anti-CD3 (OKT3) or anti-Flag antibody were added to a detergent lysate of Jurkat cells transfected with
Flag-CD3e before incubation with trypsin. The bands corresponding to CD3e and its degradation products were detected by immunoblotting first
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with antigen peptide [25–27]. Nevertheless, there is growing
evidence that TCR signaling also involves a conformational
change. Early experiments showed that monovalent forms of
certain clonotypic (anti-TCR) antibodies induce cocapping with
CD4, in what has been taken as the first evidence of a ligand-
induced conformational change in the TCR [28]. Further, the
isolated tail of CD3f is converted from a phospholipid-bound
helical form to a random coil upon tyrosine phosphorylation [29].
By using monovalent and multivalent TCR ligands, we have
recently shown that a multivalent engagement is required for
induction of the conformational change, and that TCR cross-
linking and conformational change are both required for full T cell
activation [30]. Indeed, the conformational changes associated
with the induced fit of the complementarity-determining region
loops have been proposed as a mechanism that contributes to
ligand discrimination [31]. If conformational changes in the whole
TCR complex are considered, and not only those in the
complementarity-determining regions, this mechanism can be
generalized to all TCR-pMHC interactions [32].
We have identified Nck as a ligand for the polyproline sequence
(PPS) of CD3e [17]. Within the TCR complex, CD3e is in a non-
binding state in non-stimulated T cells, but upon ligand (pMHC,
superantigen or antibody) engagement, the CD3e tail undergoes a
conformational change that exposes the PPS for Nck binding. To
understand the mechanisms that allow the transmission of the
conformational change from TCR-complex ectodomains across
the membrane to the CD3 cytoplasmic tails, we have now
investigated whether the conformational change is transmitted to
CD3 subunits other than CD3e. Using a protease-sensitivity assay,
we show that the tails of CD3e and CD3f become protected from
degradation upon induction of the conformational change. These
results suggest that the conformational change in the TCR is
transmitted to the tails, not only of CD3e but of CD3f as well. In
addition, our results suggest that contrary to our initial models
[17,33], the CD3 tails are not converted from a resting ‘‘closed’’
conformation into an active ‘‘open’’ conformation, but rather are
converted from a loose, protease-sensitive conformation to a
compact, protease-resistant conformation. We propose that both
conformations be renamed as loose and locked, respectively.
Results
The CD3 tails adopt a compact conformation upon TCR
engagement
We have previously reported that in a pull-down assay
immobilized glutathione S-transferase (GST)-Nck binds to stimu-
lated TCR complex but not to the non-stimulated complex [17].
Since Nck binds through its N-terminal SH3 domain to the PPS of
CD3e, the pull-down assay revealed a rearrangement of the CD3e
tail. The assay indicated that the non-stimulated TCR complex
was in a non-binding conformation, which we called closed-CD3
[33]. This form was converted upon stimulation into a binding
conformation, which we called open-CD3. This conformational
change was also suggested by positive immunostaining of
stimulated cells and tissues with the CD3e’s PPS-specific
monoclonal antibody APA1/1 [34,35]. Thus, the pull-down and
APA1/1 staining assays both demonstrated that the PPS of CD3e
becomes exposed after TCR engagement.
To further define ligand-induced conformational change in
TCR cytoplasmic tails, and also to study whether CD3 subunits
other than CD3e are affected, we performed a series of protease-
sensitivity assays. Since the tail of CD3e is rich in lysine and
arginine residues that are recognized as cleavage sites by trypsin
(Fig. 1A), we chose this protease for our studies. To allow
examination of the products of C-terminal-end digestion,
experiments were done in Jurkat T cells stably expressing a
human CD3e chain labeled at its N-terminus with a Flag epitope
(fe-Jk cells). Trypsin digestion of detergent lysates of fe-Jk cells
generated a CD3e partial-digestion product of 19 kDa, represent-
ing a loss of 4 kDa, which is most of the CD3e tail (Fig. 1B). The
partial digestion product was not recognized on immunoblots by
the PPS-specific antibody APA1/1, suggesting that this sequence
had been degraded. Digestion was, however, partially inhibited by
addition to the lysate of the stimulatory anti-CD3 antibody
OKT3. In contrast, the anti-Flag antibody did not inhibit
digestion. Anti-Flag stimulation of fe-Jk cells was previously
demonstrated, using the pull-down assay, to be a poor inducer
of the conformational change in the TCR, even though it induced
tyrosine phosphorylation (Fig. S1). The OKT3-protected CD3e
band was recognized by APA1/1, suggesting that the PPS was
protected (Fig. 1B). These results indicate that binding of a
conformational-change-inducing antibody to the TCR complex
renders the CD3e resistant to trypsin digestion, providing further
support that the tail of CD3e undergoes a conformational change
in response to engagement by a stimulatory antibody.
To determine whether the CD3f subunit also undergoes
conformational change, trypsin-digested Jurkat T cell lysates were
immunoblotted with antibody 448, which is specific for the C-
terminal-most 34 amino acids of CD3f. This showed that the
CD3f dimer was digested by trypsin upstream of the sequence
recognized by the antibody (Fig. 1C). Incubation with the
stimulatory antibody OKT3, but not with an irrelevant isotype-
matched antibody, partially prevented the loss of the 448 epitope.
Furthermore, reprobing the membrane with a polyclonal antibody
raised against the whole tail of CD3f detected intermediate-sized
partial-digestion products only in cell lysates that had been
incubated with OKT3 (Fig. 1C, WB anti-fcit).
Since TCR triggering with the anti-CD3 antibody OKT3 was
performed after lysis of the cells in detergent, it was unlikely that
the protective effect on the CD3e and CD3f tails was due to
shielding caused by tyrosine phosphorylation of the immune
receptor tyrosine-based activation motifs (ITAMs) or to recruit-
ment of signalling proteins such as ZAP70. Nevertheless, in order
with anti-Flag antibody and second with the PPS-specific antibody APA1/1. The asterisk indicates the presence of a protein fragment in lane 1 that
corresponds to the partial proteolysis of Flag-CD3e, probably caused by cellular proteases contained in the cell lysate. The balance sheet indicates the
percentages of protected CD3e molecules, calculated by densitometry of the anti-Flag and APA1/1 immunoblots. (C) The CD3f tails becomes
protected from proteolytic cleavage after TCR triggering. A Jurkat cell lysate was incubated with 10 mg/ml of either OKT3 or an isotypic control
antibody (OKT8) before digestion with trypsin. Immunoblotting was performed with anti-CD3f antibodies reacting with the C-terminus (448) or the
whole tail (anti-fcit). (D) Tyrosine phosphorylation does not affect the sensitivity of CD3e to trypsin proteolysis. A Jurkat cell lysate was incubated with
10 mg/ml of OKT3 in the presence of 20 mM of the src kinase inhibitor PP2 for 15 min at room temperature, before digestion with trypsin.
Immunoblotting was performed with antibody APA1/1. (E) Protection against trypsin proteolysis is independent of TCR aggregation. A Jurkat cell
lysate was preincubated with 50 mg/ml of Fab fragments of OKT3 or the isotypic control antibody 12CA5 (anti-HA), before digestion for 15 min at
37uC with the indicated concentrations of trypsin. Immunoblotting was performed with APA1/1 followed by reprobing with the 448 antiserum. The
presence of immunoglobulin light chain (L) from the anti-HA Fab fragment in the APA1/1 immunoblot is indicated.
doi:10.1371/journal.pone.0001747.g001
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inhibitor PP2 [36] in the protease sensitivity assay. The result
showed that, even in the presence of PP2, the triggered TCR
acquired resistance to trypsin digestion (Fig. 1D), suggesting that
the protection effect of TCR triggering was not due to a post-lysis
modification of the TCR. Another important control was to
demonstrate that the acquisition of resistance to trypsin was not
due to the formation of aggregates that are poorly accessible to
trypsin upon crosslinking of the TCR with the bivalent anti-CD3
antibody. Engagement of the TCR complex in Jurkat cell lysates
with a monovalent Fab fragment of OKT3, but not the incubation
with an isotype-matched irrelevant antibody, increased the
resistance of the CD3e and CD3f tails to trypsin digestion
(Fig. 1E). This result indicates that the acquisition of resistance to
trypsin digestion is not caused by aggregation of the TCR, and is
consequent with previous evidence showing, with the pull-down
assay, that a monovalent anti-CD3 antibody induces the
conformational change [17]. The results shown in Figures 1D
and 1E exclude alternate explanations, and suggest that the
acquisition of resistance to trypsin digestion is caused by a
conformational change transmitted to the CD3 tails.
The acquisition of resistance to trypsin digestion by CD3e and
CD3f was also noted when OKT3 was used to stimulate intact
Jurkat T cells before lysis, but not when an irrelevant antibody
(anti-CD4) was used (Fig. 2A). Furthermore, the protected CD3e
and CD3f bands correspond to the full-length proteins, since they
were recognized by M20 and 448, respectively, two polyclonal
antibodies specific for the C-terminal ends. This result suggests
that the conformational change involves a rearrangement of the
whole tails.
The protective effect of TCR stimulation against trypsin
digestion of CD3e and CD3f tails was seen not only with anti-
CD3 dimer antibodies (e.g. OKT3), but also with stimulatory
antibodies for the TCRa/b heterodimer. Thus, stimulation of
intact Jurkat cells with antibodies C305 and BV8, specific for the
variable Vb region, partly prevented the degradation of the CD3e
and CD3f tails by trypsin (Fig. 2B). This effect was, however, not
seen with the anti-Cb antibody Jovi.1, which is a poor inducer of
the conformational change according to the GST-Nck pull-down
assay ([17] and Fig. 2C). Isotypic differences cannot explain the
differential effect of the anti-TCR antibodies, at least for
antibodies OKT3, Jovi.1 and HP2/6 (irrelevant antibody in
Fig. 2C, lane 2) which are of the same isotype (IgG2a). These
results strongly suggest that TCR engagement induces a
conformational change that is transmitted to the cytoplasmic tails
of CD3e and f.
From the mobilities of the digestion products (Fig. 1A and 1C) it
appeared that the cytoplasmic tail of CD3e from non-triggered
TCRs was completely digested, whereas the tail of CD3f was only
partly accessible to trypsin. The estimated loss of relative mass in
the CD3f2 dimer after digestion was 16 kDa (from 32 to 16 kDa),
which is below the 24 kDa loss that would be expected if all the
CD3f tail were digested (Supplemental material Fig. S2). Upon
stimulation, partial proteolytic products were detected at 22 and
27 kDa (Fig. 1C). The sequences that separate the three Immune
receptor Tyrosine-based Activation Motifs (ITAM) in CD3f are
particularly rich in basic amino acids, and therefore in potential
trypsin-cleavage sites (Fig. 1A, 3A). Inspection of ITAM
distribution in CD3f suggests that the 27 kDa fragment could
derive from a cleavage between ITAMs B and C, and the 22 kDa
fragment from cleavage within ITAM B (Suppl. Fig. S2). The
16 kDa product resulting from digestion of CD3f in resting TCRs
could derive from cleavage between ITAMs A and B. If these
calculations are correct, they would indicate that compared with
the more membrane-distal ITAMs, ITAM A might be constitu-
tively protected from trypsin attack in the resting TCR. No
antibody specific for ITAM A was available, so to test this we
generated a truncated CD3f mutant with a Flag epitope appended
immediately after ITAM A (Fig. 3A, construct fAflag). Transfec-
tion of this construct into Jurkat cells generated disulfide-linked
Figure 2. Stimulation of living T cells provokes the adoption of
a protease-resistant conformation in CD3e and CD3f. (A) CD3
ligation in living cells protects against proteolytic cleavage. Jurkat cells
were unstimulated or stimulated for 5 min with 10 mg/ml of either anti-
CD3 (OKT3) or an irrelevant antibody (HP2/6, anti-CD4). Detergent
lysates were incubated with trypsin as in Fig. 1, and immunoblotting
was performed with APA1/1, 448 and M20, an antibody specific for the
C-terminal end of CD3e. (B) Stimulation with certain anti-TCRa/b
antibodies promotes the protease-resistant conformation in CD3e and
CD3f. Jurkat cells were stimulated for 5 min with the anti-Vb antibodies
BV8 (IgG2b) and C305 (IgM) or with the anti-Cb antibody Jovi.1 (IgG1).
Lysates were incubated with trypsin, and immunoblotting was
performed as in A. (C) Differential capacity of the anti-TCRb antibodies
to induce the conformational change determined by the pull-down
assay. Jurkat cells were stimulated with an irrelevant anti-CD4 antibody
or with the indicated antibodies to the TCR complex, as in B. Lysates
were subjected to pull-down with GST-SH3.1 (GST-Nck) or GST. The
presence of the TCR in the precipitates was revealed by immunoblot-
ting with anti-CD3e (M20). TL, total cell lysate.
doi:10.1371/journal.pone.0001747.g002
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CD3f (Fig. 3B, total lysates, TL). TCR complexes containing
either one (ffAflag) or two fAflag constructs (fAflag2) underwent
the conformational change after TCR triggering, as indicated by a
positive reaction in the GST-Nck pull-down assay (Fig. 3B).
However, fAflag was completely resistant to trypsin digestion even
in non-triggered TCRs, whereas the Flag epitope was completely
digested when appended at the C-terminal end of full-length
CD3f (Fig. 3C). These results suggest that the CD3f ITAM closest
to the membrane is permanently protected from digestion and that
the conformational change in the TCR modifies the exposure of
the second and third ITAMs of CD3f to trypsin cleavage.
Discussion
Limited proteolysis has become an established tool for the study
of conformational changes [37,38]. For instance, the atrial
natriuretic peptide receptor becomes susceptible to cleavage by
exogenously added protease when bound to its lignad [38]. In this
paper we have used limited proteolysis to study the induction of
conformational changes in the TCR complex. Our results show
that the cytoplasmic tails of CD3e and CD3f subunits extracted
from resting cells are almost completely digested by added trypsin,
but become protected upon TCR triggering. Up to now, the
strongest evidence for a conformational change in the TCR has
come from studies showing ligand-induced exposure of the PPS in
the cytoplasmic tail of CD3e [17]. One biochemical assay is based
on pull-down with immobilized GST-Nck, and has served to
demonstrate that certain stimulatory anti-CD3 antibodies [17] and
a panel of pMHC ligands [33] induce a conformational change in
the TCR. A second assay to detect these conformational changes is
based on exposure of a neo-epitope recognized by the monoclonal
antibody APA1/1. This epitope coincides with the PPS in CD3e
and reveals, like the pull-down assay, a conformational change
transmitted to the cytoplasmic tail of CD3e [34]. Through the use
of APA1/1 it has been possible to confirm that the TCR
undergoes conformational changes during antigen recognition in
vivo, and that the TCR complexes undergoing the conformational
Figure 3. The membrane-proximal ITAM of CD3f is constitutively protected from limited trypsin digestion. (A) Cartoon showing the
potential trypsin cleavage sites in CD3f and in a truncated CD3f lacking ITAMs B and C. The position of a Flag epitope appended to the C-terminal
end of both constructs is indicated. (B) The presence of fFlag or fAFlag does not alter the ligation-induced conformational switch in the TCR. GST-
SH3.1 pull-down was performed as in Fig. 2C with lysates of Jurkat cells transfected either with fFlag (JkfFlag) or fAFlag (JkfAFlag). (C) ITAM A is
constitutively condensed. JkfFlag and JkfAFlag were stimulated with antibodies and the lysates digested with trypsin as in Fig. 2C. Immunoblotting
was performed with anti-Flag antibody.
doi:10.1371/journal.pone.0001747.g003
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moreover showed that the conformational change is elicited by full
but not by partial agonist/antagonist peptides [34]. Unfortunately,
the pull-down and APA1/1 recognition assays reflect the same
molecular event (rearrangement of the PPS in the tail of CD3e)
and thus did not provide evidence of conformational change in
TCR subunits other than CD3e.
Previous evidence for conformational change in the cytoplasmic
tail of CD3f was based on in vitro biochemical studies. Isolated
CD3f cytoplasmic tails change from a lipid-bound helical
structure to an unfolded conformation upon tyrosine phosphor-
ylation [29]. These results support the earlier finding that a
synthetic peptide corresponding to the third ITAM of CD3f
adopts an a-helical structure in the non-phosphorylated form and
a b strand conformation when phosphorylated [39]. However,
both these studies were performed in cell-free systems with
synthetic peptides and recombinant proteins, in the absence of
other TCR subunits. The limited proteolysis studies reported in
this paper therefore provide the first evidence that CD3f
undergoes a conformational change within the TCR complex in
response to ligand binding. Due to the lack of appropriate
antibodies, we have not yet been able to study the effect of limited
proteolysis on CD3c and CD3d, but a model could be proposed in
which a conformational change is transmitted from the ligand-
binding ectodomains of the TCRa/b to the cytoplasmic tails of all
CD3 subunits.
The conformational change induced in CD3f, however, shows
distinct features from those confirmed for CD3e. Whereas the
whole cytoplasmic tail of CD3e is susceptible to proteolytic
degradation in the non-triggered TCR and is protected upon
stimulation, in CD3f ITAM A is protected even in non-triggered
TCRs, and stimulation extends this protection to ITAMs B and C.
Interestingly, CD3f is sequentially phosphorylated on its three
ITAMs during T cell activation (for a review see [40]). In some
cases ITAMs B and C are phosphorylated constitutively,
producing the p21 tyrosine phosphorylated form of CD3f.I n
contrast ITAM A is phosphorylated only upon TCR triggering,
yielding the p23 form. Although the detailed functional signifi-
cance of the p21 and p23 forms of CD3f is not clear, it is well-
established that phosphorylation of ITAM A defines the difference
between triggered and non-triggered TCRs. In light of our limited
proteolysis results, we suggest that, in a resting TCR, ITAM A is in
a compact conformation that is not accessible to tyrosine
phosphorylation by the priming src kinases [41], and that the
conformational change not only compacts ITAMs B and C, but
also reorients ITAM A into a conformation more susceptible to
phosphorylation.
We recently described that both TCR crosslinking and
conformational change are required for full tyrosine phosphory-
lation of different intracellular effectors [30]. In this regard, the
acquisition of protease resistance by the tail of CD3f shown in the
present study suggests that the conformational change may also
affect the phosphorylation of CD3f and, therefore, the recruitment
of ZAP70 and the subsequent phosphorylation of downstream
effectors. This requirement of the conformational change for
tyrosine phosphorylation appears to be contradicted by the
activation of tyrosine phosphorylation with the anti-flag antibody,
a poor inducer of the conformational change in Flag-CD3e-
expressing Jurkat cells (Supplemental Figure S1). Several expla-
nations can be given. The most simple is that the anti-flag
antibody induces the conformational change to a level that is
sufficient to pass a threshold for activation of tyrosine kinases. A
second possibility, is that TCR crosslinking in the absence of
conformational change is sufficient for the activation of tyrosine
kinases but not for a normal pattern of phosphorylation, i.e. TCR-
associated tyrosine kinases could be activated without the TCR
undergoing a conformational change, but the access to their
potential substrates (ITAMs and downstream effectors) would be
limited. Finally, the number of tools that we have to study the
conformational change, or conformational changes, in the TCR is
limited. The exposure of the PPS in CD3e, revealed by the GST-
Nck pull-down assay and APA1/1 epitope display [17,34], and the
trypsin sensitivity assay shown in the present study, might be only
coarse methods to understand the fine tuning of signal transduc-
tion by the TCR.
The acquisition of resistance to trypsin digestion upon TCR
stimulation suggests that, contrary to our prior prediction,
stimulation does not shift the cytoplasmic tails of the TCR from
a ‘‘closed’’ to an ‘‘open’’ conformation [17,33]. Our present data
indicate instead that the cytoplasmic tails in the non-engaged TCR
are in a loose conformation that makes them accesible to trypsin
digestion. We now prefer to name this conformation the Nck non-
binding or loose conformation. Upon antibody stimulation, a
conformational change is transmitted from the TCR ectodomains
to the CD3 cytoplasmic tails, which become packed into a more
compact structure with reduced accesibility for trypsin. This is the
Nck-binding or locked conformation. The reduced exposure of the
CD3 cytoplasmic tails to trypsin must occur simultaneously with
an increased exposure of the CD3e PPS to Nck perhaps by fixing it
into a conformation adequate for binding. We do not know the
ultimate causes that explain why a trypsin-sensitive loose confor-
mation in CD3e is incompatible with a Nck-binding conformation
of the PPS. We have however structural information (obtained by
NMR) on how the PPS binds the SH3.1 domain of Nck (Borroto
and Alarco ´n, in preparation). The CD3e polypeptide makes an
extensive fingerprint on the SH3.1 domain, where not only the
central proline residues participate, but also upstream and
downstream charged amino acids. This explains why CD3e binds
with abnormally high affinity for a SH3-ligand interaction (in the
order of 0.1 mM), and may also indicate structural requirements
for the interaction. In the loose conformation the sequences
upstream and/or downstream of the PPS-and not necessarily the
central prolines themselves-might be in non-binding conformation.
The compaction of the CD3 tails resulting in the locked
Figure 4. Model of conformational change in the cytoplasmic
tails of CD3 subunits after TCR engagement. In non-stimulated
cells, the CD3 subunits in the TCR are in a loose conformation that is
accessible to trypsin digestion. The PPS of CD3e (pink square) is in a
non-binding conformation for Nck. After TCR engagement with pMHC
or with stimulatory antibodies, the CD3 ectodomains adopt an active
conformation (symbolized with rectangular forms) that is transmitted to
the cytoplasmic tails of the CD3 subunits via a rotation and/or scissor
movement. The cytoplasmic tails close up to form a compact structure
that is less sensitive to proteolytic attack. This conformation permits
Nck-binding by CD3e.
doi:10.1371/journal.pone.0001747.g004
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appropriate conformation.
In this study we have used anti-CD3 antibodies to elicit the
conformational change that results in the trypsin-protected or
locked conformation in both CD3e and CD3f. The locked
conformation was also induced when antibodies that recognize
the variable domain of the TCRb ectodomain were used for
stimulation. We can therefore propose that a conformational
change transmitted from the ectodomains of the TCRa/b
heterodimer to the CD3 tails induces their locked conformation.
We have attempted to demonstrate that a similar rearrangement
takes place upon antigen stimulation. However these experiments
have failed, probably due to the fact that continued pMHC-TCR
interaction after lysis of the cells is necessary to preserve the
conformational change [30].
The transmission of TCR conformational change across the
plasma membrane presents a conceptual challenge. The structure
of the CD3c-CD3e dimer ectodomains led to the proposal that the
transmembrane domains of the dimer undergo a piston-like
movement. In this way, the paired G beta strands of CD3e and
CD3c (as well as those of CD3e and CD3d) would form a rigid
rod-like connector that would displace the transmembrane helices
[42]. On the other hand, monovalent Fab fragments of the anti-
CD3 antibody OKT3 bind to CD3e in a side-on orientation [43],
and this interaction induces a conformational change in the TCR
[17]. Considering this in conjunction with the electrostatic
properties of CD3e, it has been proposed that the transmission
of the conformational change might require a rotational or scissor-
like movement of both the transmembrane domains and the
cytoplasmic tails of the CD3 subunits [43]. The protease-sensitivity
data reported in the present paper support a model in which
ligand binding to the TCRa/b heterodimers somehow promotes a
combination of rotational and closing-scissor movements that
simultaneously condense and shield the cytoplasmic tails of the
CD3 subunits, while exposing key features, such as the PPS of
CD3e and ITAM A of CD3f. Studies with purified recombinant
proteins have shown that all ITAM-bearing cytoplasmic tails
studied (including those of the TCR and BCR) form oligomers in
solution [44], although the interaction is weak (Kd in the order of
10 mM). The conformational change in the TCR might exploit
this natural propensity of ITAM-bearing cytoplasmic tails to
dimerize or oligomerize, by forcing the local effective ITAM
concentration above the dissociation constant. Although the
capacity of the three ITAMs of CD3f to homodimerize has not
been measured on a one-by-one basis, it is tempting to speculate
that the protease resistance of ITAM A could be caused by a
higher propensity of this ITAM to dimerize in the resting TCR,
compared to ITAMs B and C. Alternatively, protease resistance of
ITAM A in the resting TCR could be due to the position of CD3f
in the TCR complex, i.e. the tail of CD3f could occupy an
internal position within the TCR complex, where the tails of the
other CD3 subunits could shield the membrane most proximal
region of CD3f’s tail.
In our current model, the conformational change is initiated
after binding of a cluster of two or more pMHC agonists to two or
more TCRa/b heterodimers within a multivalent TCR complex
[30]. This would generate a torque on the TCRa/b heterodimers
that could be transmitted to the CD3 dimers. In turn, this binding
would induce the rotation or sliding of the transmembrane
domains of the CD3 dimer with respect to those of the TCRa/b
heterodimers, and an ensuing transmission of this movement to
the CD3 cytoplasmic tails. Crystal structures of TCRa/b
ectodomains bound to pMHC complexes almost universally show
that the orientation of TCRa/b is approximately diagonal to the
MHC peptide-binding groove (for a review see [45]). We
hypothesize that in the context of a multivalent TCR, the
diagonal orientation imposed by pMHC binding on the two
TCRa/b heterodimers may be responsible for the torque
transmitted to the CD3 subunits.
Materials and Methods
Plasmids
The pGEX-4T1 derivative GST-SH3.1, containing the amino-
terminal SH3 domain of Ncka, was kindly provided by Dr. R.
Geha (Children’s Hospital, Harvard Medical School, Boston). The
pSRa-CD3f-Flag plasmid encoding human CD3f was generated
by PCR. The truncated CD3fA construct (pSRa-CD3fA-Flag)
expresses a protein truncated immediately after the first ITAM of
human CD3f. Both constructs encode the Flag peptide fused to
the C-terminus of the protein.
Cells
The human T cell line Jurkat was maintained in complete
RPMI 1640 supplemented with 10% fetal bovine serum (Sigma).
The Jurkat cell clone fe-Jk expressing Flag-CD3e has been
described previously [17]. The JkfAF and JkfF cell lines were
generated by stable transfection into Jurkat of the pSRa-CD3fA-
Flag and pSRa-CD3f-Flag, respectively.
Antibodies
The anti-CD3e mouse monoclonal antibody APA1/1 has been
described previously [34,35,46,47], as has the rabbit anti-CD3f
antiserum 448 [48,49]. The anti-CD3fcit rabbit antiserum was
obtained by repeatedly immunizing a white New Zealand rabbit
with a purified peptide corresponding to the complete cytoplasmic
tail of human CD3f, produced in E.coli. The anti-Cb Jovi.1 mAb
(IgG2a) and the anti-CD4 HP2/6 mAb (IgG2a) were a kind gift of
Dr. M. Owen (CRUK, London, UK) and Dr. F. Sa ´nchez-Madrid
(Hospital de La Princesa, Madrid). Hybridomas producing the
anti-CD3 mAb OKT3 (IgG2a), the anti-TCRb mAb C305 (IgM)
and the anti-CD8 OKT8 (IgG2a) were obtained from ATCC.
Goat anti-CD3e M20, mouse anti-human Vb8 BV8 (IgG2b),
mouse anti-hemagglutinin (HA) 12CA5 (IgG2a), and mouse anti-
Flag (M2) antibodies were purchased from Santa Cruz Biotech-
nology, BD-Pharmingen, Roche and Sigma, respectively. Fab
fragments were prepared using the Immunopure IgG1 Fab
Preparation kit (Pierce) and confirmed by SDS-PAGE and silver
staining.
Stimulation and pull-down assay
10
7 cells per point were collected, washed, resuspended in
RPMI and incubated without serum at 37uC for 2 h. Cells were
stimulated with 10 mg/ml soluble antibody for 5 min at 37uC and
lysed in 20 mM Tris-HCl pH 8.2, 0.3% Brij96, 140 mM NaCl,
10 mM iodoacetamide and 2 mM EDTA (lysis buffer), plus 1 mg/
ml each of leupeptin and aprotinin, and 1 mM phenyl methyl
sulfonide fluoride (PMSF). For GST pull-down assays supernatants
were first precleared with GST adsorbed to glutathione-Sepharose
(Amersham Biosciences) before precipitation with GST-SH3.1
protein adsorbed to glutahione-Sepharose [17].
Trypsin digestion
10
6 cells per point were stimulated with 10 mg/ml soluble
antibody for 5 min at 37uC and disrupted in lysis buffer without
leupeptin, aprotinin or PMSF. A total of 1 mg/ml trypsin (Sigma)
was added to the lysate and the reaction mix was incubated for
15 min at 37uC. Afterwards, 36 Laemmli’s sample buffer was
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Alternatively, postnuclear cell lysates of unstimulated cells were
incubated with the anti-CD3 antibody before trypsin digestion
under the same conditions.
Supporting Information
Supplemental Figure S1 TCR crosslinking with an antibody to
a foreign CD3 epitope results in poor stimulation. (A) Anti-Flag
stimulation of f-Jk cells is a weak inducer of the conformational
change, but strong inducer of tyrosine phosphorylation. Jurkat T
cells transfected with Flag-CD3epsilon (fepsilon-Jk cells) were
stimulated with the indicated concentrations of an anti-Flag or
anti-CD3 antibody (OKT3), lysed in Brij96, and TCR binding to
GST-SH3.1 was revealed by immunoblotting with anti-CD3zeta
antibody. (B) Compared to anti-CD3, the anti-Flag antibody
poorly activates T cells. The expression of CD69 and CD25 was
examined in fepsilon-Jk cells 24 h after stimulation with OKT3
(closed symbol) or anti-Flag (open symbol). Induction of
programmed cell death was examined 48 h after stimulation with
immobilized antibodies by propidium iodide exclusion (PI
staining) or by cell cycle analysis (% cells in sub-G1).
Found at: doi:10.1371/journal.pone.0001747.s001 (0.84 MB TIF)
Supplemental Figure S2 Expected and observed sizes of partial
trypsin digestion of the CD3zeta tail. A cartoon of the CD3epsilon
and CD3zeta subunits showing potential trypsin cleavage sites
(arrows). Transmembrane domains are indicated with grey boxes,
and the relative positions of the three ITAMs are marked. The
observed sizes of the partial digestion products were calculated
from results shown in Fig. 1C.
Found at: doi:10.1371/journal.pone.0001747.s002 (3.46 MB TIF)
Acknowledgments
We thank Drs. Simon Bartlett and Hisse M. van Santen for critical reading
of the manuscript.
Author Contributions
Conceived and designed the experiments: BA. Performed the experiments:
RR. Analyzed the data: WS. Wrote the paper: BA.
References
1. Hubbard SR, Till JH (2000) Protein tyrosine kinase structure and function.
Annu Rev Biochem 69: 373–398.
2. Weiss A, Schlessinger J (1998) Switching signals on or off by receptor
dimerization. Cell 94: 277–280.
3. Wess J (1997) G-protein-coupled receptors: molecular mechanisms involved in
receptor activation and selectivity of G-protein recognition. Faseb J 11: 346–354.
4. Wess J, Liu J, Blin N, Yun J, Lerche C, et al. (1997) Structural basis of receptor/
G protein coupling selectivity studied with muscarinic receptors as model
systems. Life Sci 60: 1007–1014.
5. Jiang G, Hunter T (1999) Receptor signaling: when dimerization is not enough.
Curr Biol 9: R568–571.
6. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, et al. (2000) A domain in
TNF receptors that mediates ligand-independent receptor assembly and
signaling. Science 288: 2351–2354.
7. Chan FK, Siegel RM, Zacharias D, Swofford R, Holmes KL, et al. (2001)
Fluorescence resonance energy transfer analysis of cell surface receptor
interactions and signaling using spectral variants of the green fluorescent
protein. Cytometry 44: 361–368.
8. Remy I, Wilson IA, Michnick SW (1999) Erythropoietin receptor activation by a
ligand-induced conformation change. Science 283: 990–993.
9. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, et al. (2000)
Fas preassociation required for apoptosis signaling and dominant inhibition by
pathogenic mutations. Science 288: 2354–2357.
10. Tolar P, Sohn HW, Pierce SK (2005) The initiation of antigen-induced B cell
antigen receptor signaling viewed in living cells by fluorescence resonance energy
transfer. Nat Immunol 6: 1168–1176. Epub 2005 Oct 1162.
11. Lin J, Weiss A (2001) T cell receptor signalling. J Cell Sci 114: 243–244.
12. Rudolph MG, Luz JG, Wilson IA (2002) Structural and thermodynamic
correlates of T cell signaling. Annu Rev Biophys Biomol Struct 31: 121–149.
13. Werlen G, Palmer E (2002) The T-cell receptor signalosome: a dynamic
structure with expanding complexity. Curr Opin Immunol 14: 299–305.
14. Alarcon B, Gil D, Delgado P, Schamel WW (2003) Initiation of TCR signaling:
regulation within CD3 dimers. Immunol Rev 191: 38–46.
15. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, et al. (1993) Three-
dimensional structure of the human class II histocompatibility antigen HLA-
DR1. Nature 364: 33–39.
16. Bachmann MF, Ohashi PS (1999) The role of T-cell receptor dimerization in T-
cell activation. Immunol Today 20: 568–576.
17. Gil D, Schamel WW, Montoya M, Sanchez-Madrid F, Alarcon B (2002)
Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational
change essential for T cell receptor signaling and synapse formation. Cell 109:
901–912.
18. Janeway CA, Jr. (1995) Ligands for the T-cell receptor: hard times for avidity
models. Immunol Today 16: 223–225.
19. Ding YH, Baker BM, Garboczi DN, Biddison WE, Wiley DC (1999) Four A6-
TCR/peptide/HLA-A2 structures that generate very different T cell signals are
nearly identical. Immunity 11: 45–56.
20. Shaw AS, Dustin ML (1997) Making the T cell receptor go the distance: a
topological view of T cell activation. Immunity 6: 361–369.
21. Davis SJ, van der Merwe PA (1996) The structure and ligand interactions of
CD2: implications for T-cell function. Immunol Today 17: 177–187.
22. Kappler J, Kubo R, Haskins K, White J, Marrack P (1983) The mouse T cell
receptor: comparison of MHC-restricted receptors on two T cell hybridomas.
Cell 34: 727–737.
23. Meuer SC, Hodgdon JC, Hussey RE, Protentis JP, Schlossman SF, et al. (1983)
Antigen-like effects of monoclonal antibodies directed at receptors on human T
cell clones. J Exp Med 158: 988–993.
24. Kaye J, Gillis S, Mizel SB, Shevach EM, Malek TR, et al. (1984) Growth of a
cloned helper T cell line induced by a monoclonal antibody specific for the
antigen receptor: interleukin 1 is required for the expression of receptors for
interleukin 2. J Immunol 133: 1339–1345.
25. Boniface JJ, Rabinowitz JD, Wulfing C, Hampl J, Reich Z, et al. (1998)
Initiation of signal transduction through the T cell receptor requires the
multivalent engagement of peptide/MHC ligands [corrected]. Immunity 9:
459–466.
26. Cochran JR, Cameron TO, Stern LJ (2000) The relationship of MHC-peptide
binding and T cell activation probed using chemically defined MHC class II
oligomers. Immunity 12: 241–250.
27. Stone JD, Stern LJ (2006) CD8 T cells, like CD4 T cells, are triggered by
multivalent engagement of TCRs by MHC-peptide ligands but not by
monovalent engagement. J Immunol 176: 1498–1505.
28. Yoon ST, Dianzani U, Bottomly K, Janeway CA, Jr. (1994) Both high and low
avidity antibodies to the T cell receptor can have agonist or antagonist activity.
Immunity 1: 563–569.
29. Aivazian D, Stern LJ (2000) Phosphorylation of T cell receptor zeta is regulated
by a lipid dependent folding transition. Nat Struct Biol 7: 1023–1026.
30. Minguet S, Swamy M, Alarcon B, Luescher IF, Schamel WW (2007) Full
activation of the T cell receptor requires both clustering and conformational
changes at CD3. Immunity 26: 43–54. Epub 2006 Dec 2021.
31. Qi S, Krogsgaard M, Davis MM, Chakraborty AK (2006) Molecular flexibility
can influence the stimulatory ability of receptor-ligand interactions at cell-cell
junctions. Proc Natl Acad Sci U S A 103: 4416–4421. Epub 2006 Mar 4413.
32. Schamel WW, Risueno RM, Minguet S, Ortiz AR, Alarcon B (2006) A
conformation- and avidity-based proofreading mechanism for the TCR-CD3
complex. Trends Immunol 27: 176–182. Epub 2006 Mar 2009.
33. Gil D, Schrum AG, Alarcon B, Palmer E (2005) T cell receptor engagement by
peptide-MHC ligands induces a conformational change in the CD3 complex of
thymocytes. J Exp Med 201: 517–522.
34. Risueno RM, Gil D, Fernandez E, Sanchez-Madrid F, Alarcon B (2005) Ligand-
induced conformational change in the T-cell receptor associated with productive
immune synapses. Blood 106: 601–608. Epub 2005 Mar 2024.
35. Risueno RM, van Santen HM, Alarcon B (2006) A conformational change
senses the strength of T cell receptor-ligand interaction during thymic selection.
Proc Natl Acad Sci U S A 103: 9625–9630. Epub 2006 Jun 9629.
36. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, et al. (1996)
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor.
Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271: 695–701.
37. Gilbert JM, Hernandez LD, Balliet JW, Bates P, White JM (1995) Receptor-
induced conformational changes in the subgroup A avian leukosis and sarcoma
virus envelope glycoprotein. J Virol 69: 7410–7415.
38. Huo X, Abe T, Misono KS (1999) Ligand binding-dependent limited proteolysis
of the atrial natriuretic peptide receptor: juxtamembrane hinge structure
essential for transmembrane signal transduction. Biochemistry 38:
16941–16951.
39. Laczko I, Hollosi M, Vass E, Hegedus Z, Monostori E, et al. (1998)
Conformational effect of phosphorylation on T cell receptor/CD3 zeta-chain
sequences. Biochem Biophys Res Commun 242: 474–479.
Shielding of CD3 Tails
PLoS ONE | www.plosone.org 8 2008 | Volume 3 | Issue 3 | e174740. Pitcher LA, Young JA, Mathis MA, Wrage PC, Bartok B, et al. (2003) The
formation and functions of the 21- and 23-kDa tyrosine-phosphorylated TCR
zeta subunits. Immunol Rev 191: 47–61.
41. Malissen B (2003) An evolutionary and structural perspective on T cell antigen
receptor function. Immunol Rev 191: 7–27.
42. Sun ZJ, Kim KS, Wagner G, Reinherz EL (2001) Mechanisms contributing to T
cell receptor signaling and assembly revealed by the solution structure of an
ectodomain fragment of the CD3 epsilon gamma heterodimer. Cell 105:
913–923.
43. Kjer-Nielsen L, Dunstone MA, Kostenko L, Ely LK, Beddoe T, et al. (2004)
Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer
complexed to the therapeutic mAb OKT3. Proc Natl Acad Sci U S A 101:
7675–7680. Epub 2004 May 7610.
44. Sigalov A, Aivazian D, Stern L (2004) Homooligomerization of the cytoplasmic
domain of the T cell receptor zeta chain and of other proteins containing
the immunoreceptor tyrosine-based activation motif. Biochemistry 43:
2049–2061.
45. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs,
peptides, and coreceptors. Annu Rev Immunol 24: 419–466.
46. Alarcon B, Ley SC, Sanchez-Madrid F, Blumberg RS, Ju ST, et al. (1991) The
CD3-gamma and CD3-delta subunits of the T cell antigen receptor can be
expressed within distinct functional TCR/CD3 complexes. Embo J 10:
903–912.
47. Borroto A, Mallabiabarrena A, Albar JP, Martinez AC, Alarcon B (1998)
Characterization of the region involved in CD3 pairwise interactions within the
T cell receptor complex. J Biol Chem 273: 12807–12816.
48. Sahuquillo AG, Roumier A, Teixeiro E, Bragado R, Alarcon B (1998) T cell
receptor (TCR) engagement in apoptosis-defective, but interleukin 2 (IL-2)-
producing, T cells results in impaired ZAP70/CD3- zeta association. J Exp Med
187: 1179–1192.
49. San Jose E, Sahuquillo AG, Bragado R, Alarcon B (1998) Assembly of the
TCR/CD3 complex: CD3 epsilon/delta and CD3 epsilon/gamma dimers
associate indistinctly with both TCR alpha and TCR beta chains. Evidence for a
double TCR heterodimer model. Eur J Immunol 28: 12–21.
Shielding of CD3 Tails
PLoS ONE | www.plosone.org 9 2008 | Volume 3 | Issue 3 | e1747